These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31732223)

  • 21. Angiogenic Response following Radioembolization: Results from a Randomized Pilot Study of Yttrium-90 with or without Sorafenib.
    Lewandowski RJ; Andreoli JM; Hickey R; Kallini JR; Gabr A; Baker T; Kircher S; Salem R; Kulik L
    J Vasc Interv Radiol; 2016 Sep; 27(9):1329-1336. PubMed ID: 27266362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
    Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
    J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective Dosimetry for Yttrium-90 Radioembolization with Resin Microspheres.
    Kappadath SC
    J Vasc Interv Radiol; 2024 May; 35(5):709-711. PubMed ID: 38663954
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma.
    Zhan C; Ruohoniemi D; Shanbhogue KP; Wei J; Welling TH; Gu P; Park JS; Dagher NN; Taslakian B; Hickey RM
    J Vasc Interv Radiol; 2020 Jan; 31(1):25-34. PubMed ID: 31422022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis.
    Kim AY; Frantz S; Brower J; Akhter N
    J Vasc Interv Radiol; 2019 Mar; 30(3):298-304.e2. PubMed ID: 30819469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization.
    Xing M; Kokabi N; Camacho JC; Kim HS
    BMC Cancer; 2018 Jan; 18(1):75. PubMed ID: 29329568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial Yttrium-90 Radioembolization of Hepatocellular Carcinoma Perfused by the Cystic Artery: Multi-institutional Feasibility Study.
    Padia SA; Johnson GE; Lewandowski RJ; Gabr A; Toskich BB
    J Vasc Interv Radiol; 2020 Dec; 31(12):2022-2027. PubMed ID: 33187861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cm.
    Kim HC; Kim YJ; Lee JH; Suh KS; Chung JW
    J Vasc Interv Radiol; 2019 Jan; 30(1):1-8. PubMed ID: 30293734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystoduodenal fistula after yttrium-90 radioembolization.
    Patel NM; Yuan J; David J
    J Clin Gastroenterol; 2010 Sep; 44(8):594-5. PubMed ID: 20216427
    [No Abstract]   [Full Text] [Related]  

  • 32. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.
    Xing M; Kokabi N; Camacho JC; Kooby DA; El-Rayes BF; Kim HS
    J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Utility of Unilobar Technetium-99m Macroaggregated Albumin to Predict Pulmonary Toxicity In Bilobar Hepatocellular Carcinoma prior to Yttrium-90 Radioembolization.
    Kallini JR; Gabr A; Kulik L; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2016 Sep; 27(9):1453-1456. PubMed ID: 27566430
    [No Abstract]   [Full Text] [Related]  

  • 34. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
    Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
    J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioembolization for the treatment of hepatocellular carcinoma.
    Kim HC
    Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraprocedural yttrium-90 positron emission tomography/CT for treatment optimization of yttrium-90 radioembolization.
    Bourgeois AC; Chang TT; Bradley YC; Acuff SN; Pasciak AS
    J Vasc Interv Radiol; 2014 Feb; 25(2):271-5. PubMed ID: 24461132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization.
    Lee JS; Lee HA; Jeon MY; Lim TS; Kim BK; Park JY; Kim DY; Ahn SH; Um SH; Han KH; Seo YS; Kim SU
    Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):739-747. PubMed ID: 31764406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
    Dawson LA
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
    [No Abstract]   [Full Text] [Related]  

  • 39. The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).
    Spreafico C; Maccauro M; Mazzaferro V; Chiesa C
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):634-8. PubMed ID: 24477451
    [No Abstract]   [Full Text] [Related]  

  • 40. Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with 90Y microspheres.
    Yim SY; Kim JD; Jung JY; Kim CH; Seo YS; Yim HJ; Um SH; Ryu HS; Kim YH; Kim CS; Shin E
    Clin Mol Hepatol; 2014 Sep; 20(3):300-5. PubMed ID: 25320734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.